Abstract

Neuroinflammation, a crucial pathological process in many neurodegenerative diseases, has gained significant attention in recent years due to its role in disease onset, progression, and therapeutic potential. highlighting new insights into the mechanisms of neuroinflammation and its implications for treating conditions such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. Advances in understanding the immune cells involved, the molecular pathways driving neuroinflammation, and the potential for immune-modulating therapies are discussed. The findings underscore the shifting paradigm in neuroimmunology, where neuroinflammation is not merely a consequence of disease but a central driver of pathology.